Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/4bf66938-2b1d-45b2-9564-987b85c82a7c/

VENUSREM

Venus Remedies Limited
Chart
1,719.50 INR
Latest Week 2026-07-10
HealthcareDrug Manufacturers - Specialty & GenericLARGE
Snapshot 2026-07-12 · 0.7w · Fresh
0.96
OS Score
68.0%
Value
95.0%
Quality
99.0%
Momentum
6/9
F-Score
0.804
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
4 of 23 passing
★
OS Composite
OS 0.960
↗
Trending Value
✗
◆
Quality × Value
QV 0.804
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
Rev +18%
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 4.06
V
Value Analysis
Cheapness relative to fundamentals
68.0%ile
P/E
22.4×
P/S
3.0×
P/B
3.5×
E/P
0.0508
FCF Yield
0.052
EBITDA/EV
0.070
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
37.00000000
/100 — 1=cheapest
VC2 (Trending Value)
59.00000000
/100
VC3 (Buyback)
60.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
95.0%ile
ROE
0.155
ROA
0.120
Net Margin
0.135
Op Margin
0.152
GPA
0.442
Current
2.44
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.179
Earn Growth
1.268
Stability
0.565
lower=better
Accruals
-0.062
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
99.0%ile
6M Return
138.3%
12M Return
277.9%
12-1 Mom
295.0%
Risk-Adj
4.06
Vol 252d
72.6%
Vol 60d
173.7%
↑ Expanding
Max DD 12M
-22.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 295% is very strong — a clear uptrend. Risk-adjusted momentum of 4.06 is excellent — strong returns relative to volatility. Near-term vol (174%) is expanding vs long-term (73%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.96
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 160 peers
Sector Value %ile
91.3%
Sector Quality %ile
91.3%
P/E z-score
-0.24
P/B z-score
-0.49
Sector Avg OS
41.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 89.0% 80.0% 79.0%
NATCOPHARM NATCO Pharma Limited 96.0% 86.0% 88.0% 68.0%
SPARC Sun Pharma Advanced Research Company Limited 96.0% 71.0% 91.0% 94.0%
STAR Strides Pharma Science Limited 95.0% 75.0% 91.0% 84.0%
AUROPHARMA Aurobindo Pharma Limited 95.0% 73.0% 83.0% 90.0%
LUPIN Lupin Limited 94.0% 64.0% 98.0% 86.0%
SAGILITY Sagility Limited 93.0% 78.0% 87.0% 64.0%
AKUMS AKUMS DRUGS AND PHARMA L 88.0% 62.0% 79.0% 83.0%
Factor Interactions
Hot but Volatile
Strong momentum (99th) but high volatility (73%). Momentum could reverse sharply.
Volatility Expanding
60-day vol (174%) significantly exceeds 252-day (73%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
47.8% avg (7 factors)
Quality
B
67.8% avg (7 factors)
Momentum
A
100.0% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends6 snapshots
Factor Persistence6 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.960—6—
Value %ile0.680—0—
Quality %ile0.950—6—
Momentum %ile0.990—6—
F-Score6.000—0—
Confidence0.891—6—
Volatility0.726—6—
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
22.38
Earnings Yield (E/P)
0.0508
Price / Sales
3.01
Price / Book
3.47
Price / Cash Flow
14.77
FCF Yield
5.2%
EBITDA / EV
7.0%
Sales Yield (1/P·S)
0.3340
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
15.5%
Return on Assets
12.0%
Net Margin
13.5%
Operating Margin
15.2%
Gross Profit / Assets
Novy-Marx GPA
44.2%
Current Ratio
2.44
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.062
MomentumPrice trend strength over different horizons
6M Return
138.3%
12M Return
277.9%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
295.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
4.06
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
17.9%
Earnings Growth (YoY)
126.8%
Earnings Stability (CV)
Lower = more stable
0.565
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
37
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
59
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
60
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity